Tango Therapeutics Inc (TNGX)
3.90
+0.34
(+9.55%)
USD |
NASDAQ |
Nov 14, 16:00
3.90
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Total Assets (Quarterly): 352.42M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 352.42M |
| June 30, 2024 | 381.45M |
| March 31, 2024 | 406.22M |
| December 31, 2023 | 402.57M |
| September 30, 2023 | 428.19M |
| June 30, 2023 | 379.33M |
| March 31, 2023 | 403.77M |
| Date | Value |
|---|---|
| December 31, 2022 | 436.47M |
| September 30, 2022 | 464.16M |
| June 30, 2022 | 448.40M |
| March 31, 2022 | 471.52M |
| December 31, 2021 | 500.16M |
| September 30, 2021 | 530.14M |
| December 31, 2020 | 207.25M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
207.25M
Minimum
Dec 2020
530.14M
Maximum
Sep 2021
415.15M
Average
417.21M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 123.24M |
| Shareholders Equity (Quarterly) | 229.17M |
| Current Ratio | 8.004 |